The study of a key molecule Caspase-1 of inflammasome in hepatitis B virus-related diseases
10.3760/cma.j.cn501113-20210512-00231
- VernacularTitle:炎症小体关键分子Caspase-1在乙型肝炎病毒相关疾病中的表达研究
- Author:
Zihao FAN
1
;
Ling XU
;
Yuan TIAN
;
Yaling CAO
;
Xiangying ZHANG
;
Zhongping DUAN
;
Feng REN
Author Information
1. 首都医科大学附属北京佑安医院 北京肝病研究所，北京 100069
- Keywords:
Caspase-1;
Chronic hepatitis B;
Acute-on-chronic liver failure;
Liver cirrhosis;
Hepatocellular carcinoma
- From:
Chinese Journal of Hepatology
2022;30(11):1158-1162
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the expression and role of asparte-specific cysteine protease (Caspase)-1, inflammasomes key molecule, in hepatitis B virus (HBV)-related diseases.Methods:HBV-related liver disease patients' serum (438 cases) and liver tissue (82 cases) samples were collected from Beijing You'an Hospital affiliated with Capital Medical University. The mRNA expression level of caspase-1 in liver tissue was detected by real-time fluorescence quantitative PCR (qRT-PCR). The protein expression level of Caspase-1 in liver tissue was detected by the immunofluorescence method. The activity of Caspase-1 was detected using the Caspase-1 colorimetric assay kit. The level of Caspase-1 in the serum was detected by an ELISA kit.Results:The results of qRT-PCR showed that the mRNA level of Caspase-1 was downregulated in patients with chronic hepatitis B (CHB), cirrhosis (LC), and hepatocellular carcinoma (HCC), while up-regulated in patients with acute-on-chronic liver failure (ACLF) ( P＜0.01) compared with normal subjects. Immunofluorescence assays showed that Caspase-1 protein levels were elevated in ACLF patients, decreased in HCC and LC patients, and slightly elevated in CHB patients. The activity of Caspase-1 was slightly higher in liver tissue from CHB, LC, and HCC patients than in the normal control group, and there was no statistically significant difference between the groups. Additionally, compared with the control group, Caspase-1 activity was significantly reduced in the ACLF group ( P＜0.01). Serum Caspase-1 levels were significantly lower in patients with CHB, ACLF, LC, and HCC than in normal subjects, and serum Caspase-1 levels were lowest in patients with ACLF ( P＜0.001). Conclusion:Caspase-1, a key molecule of inflammasomes, plays an important role in HBV-related diseases and has significant differences, showing distinct features for ACLF than other HBV-related diseases.
